studies

1238A AASLD ABSTRACTS HEPATOLOGY, October, 2015
person for WD was 1,643.15 USD. Conclusion: The prevalence
of WD was slightly lower in Korean than other countries,
showing an increase from 2009. Since about one third of WD
patients had advanced liver disease such as cirrhosis and cancer,
more efforts for early diagnosis and treatment for WD are
warranted, especially during pediatric age.
Disclosures:
The following authors have nothing to disclose: Joo Yeong Baeg, Eun Sun Jang,
Mo-ran Ki, Bo Hyun Kim, Kyung-ah Kim, Hwa Young Choi, Sook-Hyang Jeong
2114
Relapse of porphyria cutanea tarda after achieving
remission: A Meta-analysis
Maira Rizwan 1 , Karl Anderson 2 , Ashwani K. Singal 1 ; 1 Gastroenterology
and Hepatology, University of Alabama, Birmingham, AL;
2 university of texas, Galveston, TX
Background: Porphyria cutanea tarda (PCT) is due to inhibition
of hepatic uroporphyrinogen decarboxylase (UROD).
Phlebotomy and 4-aminoquinolines (hydroxychloroquine and
chloroquine, preferably low-dose) are effective treatment
options. Data comparing relapse after documenting biochemical
remission of PCT with these treatments are lacking. Methods:
Pubmed and Embase databases were searched for studies
reporting data on PCT relapse with minimum follow up for
1 year after achieving remission with either phlebotomy or
4-aminoquinolines. End point of treatment with phlebotomy
was ferritin